bortezomib
Bortezomib is a drug used to treat Multiple Myeloma, Lymphoma, Mantle Cell Lymphoma, and other conditions. Bortezomib is being actively studied in 121 studies and prior, has been studied in 319.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| National Cancer Institute (NCI) | Mayo Clinic | Irene Ghobrial, MD |
| M.D. Anderson Cancer Center | Dana-Farber Cancer Institute | Paul G. Richardson, MD |
| Dana-Farber Cancer Institute | Washington University School of Medicine | E. Steve Woodle |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
- Lymphoma, Mantle Cell
- Mantle Cell Lymphoma
- Rituximab (R)
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2021-09-21
Sep 21, 2021S
Recruiting
- Antibody-mediated Rejection
- Bortezomib
- Tehran, Iran, Islamic Republic ofSBMU
2022-01-27
Jan 27, 2022E
Active, not recruiting
- Multiple Myeloma
- Bortezomib
- Dexamethasone
- Rionero in Vulture, Potenza, ItalyIrccs Crob
2022-03-24
Mar 24, 2022H
Recruiting
- Hematological Malignancy
- Bortezomib
- Detroit, MichiganHenry Ford hospital
2021-12-23
Dec 23, 2021M
Active, not recruiting
- Solid Tumor
- Urethral Cancer
- Bortezomib
- +2 more
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2022-02-21
Feb 21, 2022M
N
Completed
- Lung Diseases, Interstitial
- +2 more
- Bortezomib
- +2 more
- Chicago, IllinoisNorthwestern University
2021-08-02
Aug 2, 2021U
Completed
- Hodgkin's Lymphoma
- Lymphoma, Non-Hodgkin
- Bortezomib
- Ruxolitinib
- Ann Arbor, MichiganUniversity of Michgan Comprehensive Cancer Center
2021-12-03
Dec 3, 2021H
Recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +2 more
- Bortezomib
- Mexico City, MexicoHospital General de México "Dr. Eduardo Liceaga"
2022-01-02
Jan 2, 2022N
Recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +2 more
- New York, New YorkNYU Langone Health
2022-03-24
Mar 24, 2022M
C
M
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +2 more
- Rochester, MinnesotaMayo Clinic in Rochester
2021-10-06
Oct 6, 2021E
Completed
- Multiple Myeloma
- Bortezomib
- +3 more
- Atlanta, GeorgiaEmory University Winship Cancer Institute
2021-11-01
Nov 1, 2021M
Completed
- Relapsed or Refractory Multiple Myeloma
- Vorinostat
- +2 more
- (no location specified)
2021-03-05
Mar 5, 2021P
Recruiting
- Multiple Myeloma
- Myeloma
- Isatuximab
- +3 more
- Poitiers, FranceCHU Poitiers
2021-11-03
Nov 3, 2021P
Recruiting
- Amyloidosis; Systemic
- Daratumumab
- +2 more
- Beijing, ChinaPeking Union Medical College Hospital
2021-05-31
May 31, 2021N
Completed
- Chronic Myeloid Leukemia (CML)
- +4 more
- Bortezomib
- NK cells
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022S
Completed
- Multiple Myeloma
- Bortezomib
- +2 more
- Westwood, KansasThe University of Kansas Medical Center
2021-05-24
May 24, 2021G
Active, not recruiting
- Neuroblastoma Recurrent
- DFMO
- Bortezomib
- Little Rock, Arkansas
- +5 more
2022-02-16
Feb 16, 2022D
Terminated
- Waldenstrom's Macroglobulinemia
- Everolimus
- +2 more
- Boston, MassachusettsDana-Farber Cancer Institute
2021-04-22
Apr 22, 2021J
Completed
- Acute Myelogenous Leukemia
- Bortezomib
- Doxil
- Sacramento, CaliforniaUniversity of California Comprehensive Cancer Center
2021-02-04
Feb 4, 2021N
Recruiting
- GVHD
- Bortezomib
- Cyclophosphamide
- New York, New YorkNew York University School of Medicine
2021-04-20
Apr 20, 2021C
Completed
- Contiguous Stage II Mantle Cell Lymphoma
- +5 more
- bortezomib
- +9 more
- Duarte, California
- +1 more
2022-01-12
Jan 12, 2022D
Active, not recruiting
- Multiple Myeloma
- Bortezomib
- +2 more
- Denver, Colorado
- +7 more
2022-02-11
Feb 11, 2022